Modulators of TNF-α signaling

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9579325
APP PUB NO 20150126512A1
SERIAL NO

14553313

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compounds which are modulators of TNF-α signaling and methods of use thereof for treating a patient having a TNF-α mediated condition. The compounds can be represented by the following structural formulas:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENZYMEONE KENDALL SQUARE CAMBRIDGE MA 02139

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Biemann, Hans-Peter Cambridge, US 6 50
Hirth, Bradford H Littleton, US 31 349
Kane, John L Maynard, US 14 167
Nahill, Sharon R Belmont, US 6 16
Qiao, Shuang San Diego, US 6 24
Sneddon, Scott F Salem, US 7 57
Vinick, Frederic Mechanicville, US 9 115
Williams, John M Hopkinton, US 55 685

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00